...
首页> 外文期刊>Protoplasma: An International Journal of Cell Biology >In vitro toxicity and antidiabetic activity of a newly developed polyherbal formulation (MAC-ST/001) in streptozotocin-induced diabetic Wistar rats
【24h】

In vitro toxicity and antidiabetic activity of a newly developed polyherbal formulation (MAC-ST/001) in streptozotocin-induced diabetic Wistar rats

机译:新开发的多草药配方(MAC-ST / 001)在链脲佐菌素诱导的糖尿病Wistar大鼠中的体外毒性和抗糖尿病活性

获取原文
获取原文并翻译 | 示例
           

摘要

The present study was designed to investigate the hypoglycemic effect of an aqueous extract of MAC-ST/001 (a new polyherbal formulation) which was given once daily to rats at different doses. The animals were divided into diabetic and nondiabetic control groups. The duration of each experiment lasted from 1 week to 1 month, and the results were compared with that of the standard hypoglycemic drug glibenclamide (10 mg/kg), which was given once daily. In this study, biochemical and histopathological parameters were studied in streptozotacin (STZ) (single intraperitoneal injection of 55 mg/kg)-induced diabetic rats. The diabetic rats showed a significant (p < 0.05 and p < 0.01) decrease in their body weight and serum amylase with marked elevation in blood glucose, serum cholesterol, blood urea nitrogen, creatinine, alkaline phosphatase, and serum transaminases (AST and ALT) after 1 week till the 28th day of diabetes. Cytotoxicity of MAC-ST/001 formulation was also studied on C2C12, 3T3-L1, and HepG2 cells through MTT assay. Histological examination of the liver and pancreas of normal control, diabetic control, and drug-treated rats revealed significant results. Finally, it was concluded that administration of this MAC-ST/001 extract reversed most blood and tissue changes caused by STZ-induced diabetes in rats.
机译:本研究旨在研究MAC-ST / 001(一种新的多草药配方)水提取物的降血糖作用,该提取物每天以不同剂量给予大鼠。将动物分为糖尿病和非糖尿病对照组。每个实验的持续时间为1周至1个月,并将结果与​​标准降糖药格列本脲(10 mg / kg)每天一次的结果进行比较。在这项研究中,研究了链脲佐菌素(STZ)(单次腹膜内注射55 mg / kg)诱导的糖尿病大鼠的生化和组织病理学参数。糖尿病大鼠的体重和血清淀粉酶显着降低(p <0.05和p <0.01),血糖,血清胆固醇,血尿素氮,肌酐,碱性磷酸酶和血清转氨酶(AST和ALT)明显升高1周后至糖尿病第28天。还通过MTT分析研究了MAC-ST / 001制剂对C2C12、3T3-L1和HepG2细胞的细胞毒性。正常对照,糖尿病对照和药物治疗大鼠的肝脏和胰腺的组织学检查显示出显着结果。最后,得出的结论是,施用这种MAC-ST / 001提取物可逆转大多数由STZ诱导的糖尿病引起的血液和组织变化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号